London afternoon: Stocks perk up slightly
15th Jul 2010 13:06
London's leading shares are posting minimal gains in afternoon deals with Wall Street expected to start higher. Metal prices have recovered and mining stocks are not such a drag on the index as they were in the first few hours of trading, though Kazakhmys and Rio Tinto are amongst the major fallers
Read moreBEFORE THE BELL: US Stock Futures Rise After J.P. Morgan Results
15th Jul 2010 12:16
By Barbara Kollmeyer U.S. stock futures moved higher on Thursday after J.P. Morgan Chase beat expectations on earnings, which soothed some investor news rattled by news of slowing Chinese growth. Futures for the Dow Jones Industrial Average reversed direction, rising 21 points to 10327, whi
Read moreLondon midday: Footsie recovers equilibrium
15th Jul 2010 12:05
Leading shares are mixed, with laggards marginally in the majority among FTSE 100 constituents although the index itself ended the morning in positive territory. Metal prices have recovered and mining stocks are not such a drag on the index as they were in the first two hours of trading. Global in
Read moreN AMERICAN MORNING BRIEFING:Stocks Seen Flat; JP -2-
15th Jul 2010 11:28
U.S. investment bank Goldman Sachs Group Thursday raised its 12-month forecast for gold by a modest 1.5% to $1,355 a troy ounce, citing a prolonged period of low interest rates and persistent concerns over European sovereign debt. -By David Crawshaw, Dow Jones Newswires; +44 207 842 9252; david.
Read moreN AMERICAN MORNING BRIEFING:Stocks Seen Flat; JP Morgan Eyed
15th Jul 2010 11:28
DJIA Futures 10313.5 +5.5 +0.1% S&P 500 Futures 1091.1 +0.0 +0.0% Nasdaq Futures 1854.0 +2.8 +0.1% Above are as of 0615 ET FTSE 100 5239.4 -14.1 -0.3% Xetra DAX 6214.5 +4.7 +0.1% CAC40 3630.1 -2.9 -0.1% Above are as of 0
Read moreBEFORE THE BELL: US Stock Futures Mixed; Eyes On J.P. Morgan
15th Jul 2010 11:04
By Barbara Kollmeyer U.S. stock futures were mixed on Thursday as investors geared up for key earnings from J.P. Morgan and a slew of U.S. economic data, and absorbed news on slowing Chinese growth. Futures for the Dow Jones Industrial Average fell 7 points to 10299, while those for the S&P
Read moreUPDATE: Glaxo To Book GBP1.57B To Settle Litigation
15th Jul 2010 09:32
(Adds detail.) By Steve McGrath Of DOW JONES NEWSWIRES LONDON (Dow Jones)--GlaxoSmithKline PLC (GSK) Thursday said it would book a legal charge of GBP1.57 billion in the second quarter to settle long-standing legal cases relating to its Paxil and Avandia drugs and a U.S. government pro
Read moreMARKET TALK: GSK Avandia News Clearly Positive - Evolution
15th Jul 2010 09:13
0813 GMT [Dow Jones] The FDA's vote in favor of keeping Avandia on the U.S. market is clearly good news for GlaxoSmithKline (GSK.LN), says Evolution Securities. It means they will retain the two additional years of profits and it reduces the scope for additional legal costs. It also reduces the like
Read moreUK MARKET TALK ROUNDUP: SHARES GAINING
15th Jul 2010 09:13
Stocks on the rise in the UK today. Compiled by Dow Jones Newswires Markets Desk, [email protected] Contact us in London. +44-20-7842-9464 [email protected] 0813 GMT [Dow Jones] The FDA's vote in favor of keeping Avandia on the U.S. market is clearly good news for GlaxoSmithKlin
Read moreLondon open: Miners offset positive company news
15th Jul 2010 08:20
London's blue chips have opened lower as weak miners overshadow a number of positive company statements. Kazakhmys is leading the fallers, closely followed by Xstrata, Eurasian Natural Resources, Antofagasta, Vedanta Resources, Lonmin and Rio Tinto. On the positive side, global information service
Read moreGlaxo To Book GBP1.57B To Settle Litigation, Including Avandia
15th Jul 2010 08:15
By Steve McGrath Of DOW JONES NEWSWIRES LONDON (Dow Jones)--GlaxoSmithKline PLC (GSK) Thursday said it would book a legal charge of GBP1.57 billion in the second quarter to settle long-standing legal cases relating to its Paxil and Avandia drugs and a U.S. government probe into a Puerto Ric
Read moreLondon pre-open: Dull start foreseen despite Glaxo verdict
15th Jul 2010 07:38
After London put in a strong finish yesterday there were hopes that the market would resume its advance today but last night's middling performance by US stock markets appears to have put paid to those hopes. Traders are expecting the FTSE 100 to open lower, probably by around 16 points. A cloud
Read moreMARKET TALK: GSK May See Relief Rally On Avandia News >GSK.LN
15th Jul 2010 07:32
0632 GMT [Dow Jones] A modest rally in GlaxoSmithKline's (GSK.LN) shares could follow after the FDA voted in favor of keeping Avandia on the US market, says Citigroup. The brokerage notes the withdrawal of Avandia could have reduced the group's '11 EPS by 3.3%, or 6.4% in the event of worldwide with
Read moreUK MARKET TALK ROUNDUP: BROKERS COMMENTS
15th Jul 2010 07:32
Broker comments in the UK today. Compiled by Dow Jones Newswires Markets Desk, [email protected] Contact us in London. +44-20-7842-9464 [email protected] 0632 GMT [Dow Jones] A modest rally in GlaxoSmithKline's (GSK.LN) shares could follow after the FDA voted in favor of keeping
Read moreMARKET TALK: Debate on GlaxoSmithKline's Avandia To Continue
15th Jul 2010 07:24
0624 GMT [Dow Jones] The debate on GlaxoSmithKline's (GSK.LN) Avandia medicine will likely continue, despite the FDA Advisory Committee voting in favor of keeping the drug on the U.S. market, says Jefferies. While the shares responded positively in the U.S. following the announcement, says there may
Read more